(Q40666560)

22 September 2017

title

Cytotoxic activity of 6-alkynyl- and 6-alkenylpurines (English)

1 reference

22 September 2017

2

Lise-Lotte Gundersen

1 reference

22 September 2017

4

Frode Rise

1 reference

22 September 2017

Anders Bråthe

1

1 reference

22 September 2017

Jon Nissen-Meyer

series ordinal

3

1 reference

22 September 2017

Bjørn Spilsberg

series ordinal

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

22 September 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

877-880

1 reference

Antioxidant activity of synthetic cytokinin analogues: 6-alkynyl- and 6-alkenylpurines as novel 15-Lipoxygenase inhibitors

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Drug antioxidant effects. A basis for drug selection?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Current status of antioxidant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Cytotoxic and antibacterial activity of 2-oxopurine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Synthesis and cytostatic activity of substituted 6-phenylpurine bases and nucleosides: application of the Suzuki-Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Covalent analogues of DNA base-pairs and triplets. Part 2: synthesis and cytostatic activity of bis(purin-6-yl)acetylenes,-diacetylenes and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Analogs of 6-methyl-9.beta.-D-ribofuranosylpurine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Antiviral activity of C-alkylated purine nucleosides obtained by cross-coupling with tetraalkyltin reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

Convenient syntheses of 6-methylpurine and related nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900011-8

7 January 2021

10.1016/S0960-894X(03)00011-8

Identifiers

DOI

1 reference

22 September 2017

1 reference